AHA comments on the Health Resources and Services Administrations interim final rule that would further delay the effective date for the implementation of the Affordable Care Act provision requiring a 340B Drug Pricing Program ceiling price calculation methodology and application of civil monetary penalties for violations of the ceiling price.
The information below supplements the March 29, 2018 memorandum AHA’s outside counsel prepared regarding 340B claims submission during the legal ch
The Metro Section Council meets three times a year and actively advises the AHA on advocacy positions, public policy issues, and member service strategies.…
The Small/Rural Section Council meets three times a year and actively advises the AHA on advocacy positions, public policy issues, and member servi
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions regarding “Effective Administration of the 340B Drug Pricing Program.”
Letter to U.S. Court of Appeals for the D.C. Circuit providing MAC notices as exhibits re: 340B appeals
June 14, 2018 - Appellants provide two recent notices issue by Medicare Administrative Contractors (MACs).
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, and our clinician partners – including more than 270,000…